Commonwealth Equity Services’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $512K | Sell |
|
|||||
|
2025
Q2 | $425K | Buy |
|
|||||
|
2025
Q1 | $370K | Sell |
|
|||||
|
2024
Q4 | $395K | Buy |
|
|||||
|
2024
Q3 | $440K | Sell |
|
|||||
|
2024
Q2 | $479K | Buy |
|
|||||
|
2024
Q1 | $449K | Sell |
|
|||||
|
2023
Q4 | $444K | Sell |
|
|||||
|
2023
Q3 | $485K | Sell |
|
|||||
|
2023
Q2 | $612K | Sell |
|
|||||
|
2023
Q1 | $833 | Sell |
|
|||||
|
2022
Q4 | $867K | Buy |
|
|||||
|
2022
Q3 | $815K | Sell |
|
|||||
|
2022
Q2 | $868K | Sell |
|
|||||
|
2022
Q1 | $1.06M | Buy |
|
|||||
|
2021
Q4 | $991K | Buy |
|
|||||
|
2021
Q3 | $971K | Buy |
|
|||||
|
2021
Q2 | $842K | Sell |
|
|||||
|
2021
Q1 | $821K | Buy |
|
|||||
|
2020
Q4 | $660K | Buy |
|
|||||
|
2020
Q3 | $534K | Sell |
|
|||||
|
2020
Q2 | $601K | Sell |
|
|||||
|
2020
Q1 | $519K | Sell |
|
|||||
|
2019
Q4 | $664K | Buy |
|
|||||
|
2019
Q3 | $574K | Buy |
|
|||||
|
2019
Q2 | $421K | Sell |
|
|||||
|
2019
Q1 | $455K | Sell |
|
|||||
|
2018
Q4 | $426K | Sell |
|
|||||
|
2018
Q3 | $785K | Sell |
|
|||||
|
2018
Q2 | $789K | Buy |
|
|||||
|
2018
Q1 | $754K | Buy |
|
|||||
|
2017
Q4 | $764K | Buy |
|
|||||
|
2017
Q3 | $832K | Sell |
|
|||||
|
2017
Q2 | $837K | Sell |
|
|||||
|
2017
Q1 | $843K | Sell |
|
|||||
|
2016
Q4 | $757K | Sell |
|
|||||
|
2016
Q3 | $907K | Buy |
|
|||||
|
2016
Q2 | $789K | Sell |
|
|||||
|
2016
Q1 | $848K | Sell |
|
|||||
|
2015
Q4 | $1.15M | Buy |
|
|||||
|
2015
Q3 | $987K | Buy |
|
|||||
|
2015
Q2 | $863K | Buy |
|
|||||
|
2015
Q1 | $746K | Buy |
|
|||||
|
2014
Q4 | $621K | Sell |
|
|||||
|
2014
Q3 | $1.04M | Buy |
|
|||||
|
2014
Q2 | $639K | Buy |
|
|||||
|
2014
Q1 | $370K | Buy |
|
|||||
|
2013
Q4 | $221K | Buy |
|